Who owns NEUROSENSE THERAPEUTICS LTD?
- Ticker: NRSN
- CUSIP Number: m74240108
Tip: Access positions for across all investors
Analyze quarterly positions in Neurosense Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurosense Therapeutics stock
Who bought or sold NEUROSENSE THERAPEUTICS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| UBS Group | 109k | $78k | 121% | Jun 2026 |
|
| Independent Advisor Alliance | 100k | $72k | 100% | Jun 2026 |
|
| Yorkville Advisors Global | 78k | $56k | 0% | Jun 2026 |
|
| Commonwealth Equity Services | 23k | $16k | 0% | Jun 2026 |
|
| Pnc Financial Services | 21k | $15k | 0% | Jun 2026 |
|
| Pathstone Holdings | 17k | $12k | 0% | Jun 2026 |
|
| Geode Capital Management | 16k | $11k | 0% | Jun 2026 |
|
| XTX Topco | 12k | $8.3k | 100% | Jun 2026 |
|
| Creative Planning | 11k | $8.2k | -4% | Jun 2026 |
|
| Hrt Financial | 11k | $7.0k | 100% | Jun 2026 |
|
| Jones Financial Companies, L.L | 1.0k | $757.000000 | 0% | Jun 2026 |
|
| SBI Securities | 255.00 | $184.008000 | -4% | Jun 2026 |
|
Who sold out of Neurosense Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Mar 2026 | 44k | $34k |
| Meitav Dash Investments | Mar 2026 | 40k | $30k |
| Jane Street | Mar 2026 | 29k | $22k |